Studies on interactions between traditional herbal and western medicines. I. Effects of Sho-seiryu-to on the pharmacokinetics of carbamazepine in rats

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 5, 1999, Pages 527-531

  Ohnishi, Noriaki ^a   Yonekawa, Yasufumi ^a   Nakasako, Shinji ^a   Nagasawa, Kazuki ^a   Yokoyama, Teruyoshi ^a   Yoshioka, Mutsunobu ^b   Kuroda, Kazuo ^b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b TAKARAZUKA CITY HOSPITAL   (Japan)

Author keywords

Carbamazepine; Carbamazepine 10,11 epoxide; Pharmacokinetic interaction; Protein binding; Rat; Sho seiryu to (TJ 19)

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; SHO SEIRYU TO; TJ 19; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; HERBAL MEDICINE; MALE; MEAN RESIDENCE TIME; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0033020410     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.527     Document Type: Article

References (30)

1. Iwai A., Sugiyama Y., Kawakami A., Ueno K., Jpn. J. TDM, 8, 57-64 (1991).
2. Hasegawa T., Yamaki K., Nadai M., Muraoka I., Wang L., Takagi K., Nabeshima T., Int. J. Clin. Pharmacol. Ther., 32, 57-61 (1994).
3. Homma M., Oka K., Ikeshima K., Takahashi N., Niitsuma T., Fukuda T., Itoh H., J. Pharm. Pharmacol., 47, 687-692 (1995).
4. Hasegawa T., Yamaki K., Muraoka I., Nadai M., Takagi K., Nabeshima T., Antimicrobial Agents and Chemotherapy, 39, 2135-2137 (1995).
5. Qi J., Toyoshima A., Honda Y., Mineshita S., J. Med. Dent. Sci., 44, 31-35 (1997).
6. Uno T., Ohkubo T., Sugawara K., Higashiyama A., Motomura S., Iyakuhin-Sogosayo-Kenkyu, 21, 139-145 (1998).
7. Cyong J., Kampo Igaku, 19, 57-62 (1995).
8. Baba S., et al., Jibi Rinsyo, 88, 389-405 (1995).
9. Levy R. H., Mattson R. H., Meldrum B. S. (ed.), "Antiepileptic Drugs," 4th ed., Raven Press, New York, 1995.
10. Kerr B. M., Thummel K. E., Wurden C. J., Klein S. M., Kroetz D. L., Gonzalez F. J., Levy R. H., Biochem. Pharmacol., 47, 1969-1979 (1994).
11. Lertratanangkoon K., Horning M. G., Drug Metab. Dispos., 10, 1-10 (1982).
12. Wilkinson G. R., J. Pharmacokin. Biopharmaceut., 24, 475-490 (1996).
13. Spina E., Pisani F., Perucca E., Clin. Pharmacokinet., 31, 198-214 (1996).
14. Garg S. K., Kumar N., Bhargava V. K., Prabhakar S. K., Clin. Pharmacoi. Ther., 64, 286-288 (1998).
15. Kimura M., Nakamura H., Omori S., Kitada K., Xenobio. Metabol. Dispos., 11 (Suppl), S 225 (1996).
16. Doumas B. T., Watson W. A., Biggs H. G., Clin. Chim. Acta, 31, 87-96 (1971).
17. Shinoda M., Akita M., Hasegawa M., Nadai M., Hasegawa T., Nabeshima T., Biol. Pharm. Bull., 18, 1289-1291 (1995).
18. Yamaoka K., "Drug Disposition Analysis by Microcomputers," Nankodo, Tokyo, 1984.
19. Turner P. V., Renton K. W., Can. J. Physiol. Pharmacol., 67, 582-586 (1989).
20. Kimura M., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H., Biol. Pharm. Bull., 16, 722-725 (1993).
21. Yoshinaga K., Maemura S., Atkinson C., Mulhern M., Jpn. Pharmacol. Ther., 23, S1777-S1792 (1995).
22. Mitsuhashi H. (ed.), "Integrated Essentials Shoyakugaku," 3rd ed., Nankodo, Tokyo, 1989.
23. Nishimura N., Naora K., Hirano H., Iwamoto K., J. Pharm. Pharmacol., 50, 231-236 (1998).
24. Cheesman M. J., Reilly P. E., Biochem. Pharmacol., 56, 473-481 (1998).
25. Kanamoto I., Kodachi M., Horikoshi I., Koizumi T., Yakugaku Zasshi, 108, 772-776 (1988).
26. Hosoya J., Nagaoka H., Nakagawa Y., Jpn. J. Hosp. Pharm., 19, 203-208 (1993).
27. Kojima K., Mizukami H., Tazawa T., Nose M., Inoue M., Ogihara Y., Biol. Pharm. Bull., 21, 426-428 (1998).
28. Ohnishi T., Yoneyama H., Hamamoto T., Ishida T., Takahara J., Ichikawa Y., Am. J. Chinese Med., 14, 143-151 (1996).
29. Lin S., Hou S., Wu W., Chen S., Young T., J. Pharmacobio-dyn., 14, 201-206 (1991).
30. Mattson G. F., Mattson R. H., Cramer J. A., Ther. Drug Monit., 4, 181-184 (1982).